Tharimmune, Inc.
THAR
$2.97
-$0.03-1.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -5.01% | 47.70% | 14.53% | 16.71% | 3.03% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.01% | 8.49% | 52.00% | 109.51% | 0.38% |
| Operating Income | 22.01% | -8.49% | -52.00% | -109.51% | -0.38% |
| Income Before Tax | 20.21% | -12.66% | -54.44% | -108.55% | 0.50% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 20.21% | -12.66% | -54.44% | -108.55% | 0.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.21% | -12.66% | -54.44% | -108.55% | 0.50% |
| EBIT | 22.01% | -8.49% | -52.00% | -109.51% | -0.38% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 73.32% | 61.22% | 79.99% | 93.78% | 95.36% |
| Normalized Basic EPS | 73.32% | 61.21% | 79.99% | 93.78% | 95.36% |
| EPS Diluted | 73.32% | 61.22% | 79.99% | 93.78% | 95.36% |
| Normalized Diluted EPS | 73.32% | 61.21% | 79.99% | 93.78% | 95.36% |
| Average Basic Shares Outstanding | 199.06% | 190.47% | 671.94% | 3,249.13% | 2,042.76% |
| Average Diluted Shares Outstanding | 199.06% | 190.47% | 671.94% | 3,249.13% | 2,042.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |